Next Financial Group’s Adaptive Biotechnologies ADPT Stock Holding History

Next Financial Group’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$5K	Sell	199 -366	-65%	-$11.2K	﹤0.01%	2391
2021 Q3	$19K	Hold	565	–	–	﹤0.01%	1808
2021 Q2	$23K	Buy	565 +17	+3%	+$661	﹤0.01%	1685
2021 Q1	$22K	Buy	548 +1	+0.2%	+$54	﹤0.01%	1595
2020 Q4	$33K	Buy	+547	New	+$28.2K	﹤0.01%	1335

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Next Financial Group's ADPT Position: Q4 2021 in Review

Next Financial Group reduced its Adaptive Biotechnologies (ADPT) stake by 65% in Q4 2021, selling an estimated $11.2K and leaving 199 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

Next Financial Group first reported a position in ADPT in Q4 2020 and has held it in 5 quarters since. The position peaked at $33K in Q4 2020. 214 funds tracked by Wall St. Rank hold ADPT as of Q4 2021.

Next Financial Group held 199 shares of Adaptive Biotechnologies worth $5K as of Q4 2021.
Next Financial Group sold 366 Adaptive Biotechnologies shares in Q4 2021, an estimated $11.2K.
Adaptive Biotechnologies made up ﹤0.01% of Next Financial Group's portfolio in Q4 2021, its #2391 holding.
Next Financial Group first reported a position in Adaptive Biotechnologies in Q4 2020 and has held it in 5 quarters since.
Next Financial Group's Adaptive Biotechnologies position peaked at $33K in Q4 2020.
214 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q4 2021.

Based on Next Financial Group's 13F filing for Q4 2021, filed 15 Feb 2022.